J. van de Wetering

Erasmus Medical Center Rotterdam
Dept. of Internal Medicine/Nephrology
Rotterdam
Netherlands

j.vandewetering.1@erasmusmc.nl

More information

Presentations of this speaker
Wednesday

8 Mar

17:30 - 17:42h at Johan de Meesterzaal Colorectal carcinoma after renal transplantation: Screening looks like a valuable option C.A.J. Oudmaijer, J.I. Roodnat, J. Kal-van Gestel, I. Lansdorp-Vogelaar, A.J. Hoitsma, T. Luth, J. van de Wetering
Wednesday

8 Mar

17:54 - 18:06h at Willem Pijperzaal Alemtuzumab is superior to ritxumab as induction therapy in ABO incompatible kidney transplantation A.E. de Weerd, M. van Agteren, J. Kal-van Gestel, J. van de Wetering, M.G.H. Betjes
Thursday

9 Mar

9:12 - 9:24h at Willem Pijperzaal EXPloring attitudes and factors influencing reproductive Choices in renal Transplant patients (EXPeCT-study) M.C. van Buren, D.K. Beck, P. de Haan, J. van de Wetering, E.K. Massey
Thursday

9 Mar

10:00 - 10:12h at Hendrik Marsmanzaal Identification of kidney transplant patients at risk for skin cancer by differentially methylated regions in t cells F.S. Peters, A.M.A. Peeters, P.R. Mandaviya, J. van de Wetering, M.G.H. Betjes, C.C. Baan, K. Boer
Thursday

9 Mar

10:12 - 10:24h at Willem Pijperzaal From proposal to practice: participation of compatible donor-recipient pairs in the Dutch kidney exchange program M. de Klerk, W. Zuidema, E.K. Massey, W. Weimar, J. van de Wetering
Thursday

9 Mar

12:30 - 12:45h A search for a biomarker to predict belatacept-resistant rejection in kidney transplantation G.N. de Graav, C.C. Baan, M.C. Clahsen-van Groningen, R. Kraaijeveld, M. Dieterich, W. Verschoor, D.L. Roelen, M. Cadogan, J. van de Wetering, J. van Rosmalen, W. Weimar, D.A. Hesselink
Thursday

9 Mar

12:30 - 12:45h Conversion from tacrolimus-based to everolimus-based immune-suppressive therapy 3 months after living-donor kidney trans-plantation: A randomized-controlled clinical trial R. Bouamar, N.M. Shuker, J.A.J. Osinga, M.C. Clahsen-van Groningen, J. Damman, C.C. Baan, J. van de Wetering, A.T. Rowshani, J. Kal-van Gestel, W. Weimar, T. van Gelder, D.A. Hesselink
Thursday

9 Mar

12:45 - 13:00h Towards a conditional approach to anonymity in the Netherlands? – a multi-center prospective study among anonymous donors and recipients M. Pronk, D. Slaats, I.M. Dooper, D.B. Pilzecker, J. Vervelde, K.A.M.I. van der Pant, R.A.M. Meijer, M.H. van Vliet, C. Schrauwers, F.E. van Reekum, J.M. Wierdsma, H.J.A. Dackus, P.T.R. Ulrichts, F.J.M.F. Dor, W. Weimar, J. van de Wetering, W. Zuidema, E.K. Massey
Thursday

9 Mar

12:45 - 13:00h “What if this is my chance to save my life?” The patient perspective on public solicitation of living kidney donors M. Pronk, D. Slaats, W. Zuidema, M.T. Hilhorst, F.J.M.F. Dor, M.G.H. Betjes, W. Weimar, J. van de Wetering, E.K. Massey
Thursday

9 Mar

13:00 - 13:15h Mental disorders among unspecified living kidney donors S.Y. Ismail, W. Zuidema, J. van de Wetering, M.T. Hilhorst, L. Timmerman, E.K. Massey, J.N.M Ijzermans, J.J.V. van Busschbach, W. Weimar
Thursday

9 Mar

13:00 - 13:15h Living kidney donation a major life event - What do the donors say? M. Pronk, L. Timmerman, S. Janki, J. van de Wetering, W. Zuidema, J.N.M Ijzermans, J.J.V. van Busschbach, W. Weimar, E.K. Massey